Together, these data indicated that liver-specific Prmt5 deficiency prominently inhibits Akt/N-Ras-derived hepatocarcinogenesis partially by diminishing Akt1 phosphorylation, providing an exploration of PRMT5-related pathogenesis in primary HCC models. Here, AKT1 is linked to hepatocellular carcinoma.